Search Results

You searched for : Favipiravir  

	Dr. Reddy’s Laboratories recently terminated the trial study of Avigan in Kuwait ... Jan 28
	Dr. Reddy's, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS Tablets ... Dec 22
	Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ... Nov 23
	No significant clinical benefit with Umifenovir addition in COVID-19 treatment: Glenmark clinical study Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ... Oct 21
	Active COVID-19 cases in Orissa comes down to 25,000 Odisha has consistently been witnessing a declining trend in COVID-19 cases... Oct 16
	Indoco Remedies launches FEVINDO : 400 mg Favipiravir Now Indoco joins Favipiravir production with 400mg tablets... Sep 28
	Hetero's new Favivir packaging for Covid-19 with 800 mg dosage cuts pill burden The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India ... Sep 26
	Avifavir: Russia declares supply to 17 more countries with Covid-19 drug Russia pushes the cheapest covid drug Avifavir... Sep 25
	Dr. Reddy's anti viral drug Avigan produced promising result in treating COVID-19 patients in Japan Completed phase 3 clinical study paves way for approval request... Sep 24
	Russia approves 1st COVID-19 prescription drug for sale Coronavir's approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avifavir, in May... Sep 19
	BDR Pharma to launch 400mg Favipiravir tablets at Rs 990 for 10 tablets After 200 mg favipiravir tablets BDR to launch 400 mg Favipiravir tablets under brand name BDFAVI... Sep 07
	Brinton gets DCGI approval ; Faviton (Favipiravir) 400 mg ; Rs 79 per tablet Brinton Pharma makes Covid treatment manageable by launching 400 mg tablets at Rs 79... Aug 21
	Now Dr Reddy's also launches Favipiravir named Avigan Favipiravir licensed from Fujifilm by Dr Reddy's ... Aug 20
	Fusion Health Care launches COVID-19 drug favipiravir and an immunity booster Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name ... Aug 18
	India's Sun Pharma has started nafamostat mesylate trial for COVID-19 Sun Pharma testing pancreatitis drug to battle Covid-19 ... Aug 13
	India's Shortage Of Remdesivir Is Easing Cipla's launch of remdesivir in late June, along with subsequent launches by others, has helped ease supply bottlenecks in India... Aug 12
	Glenmark introduces higher strength 400 mg FabiFlu tablets for COVID-19 treatment Glenmark the first company to launch Favipiravir in India now launches 400 mg tablets... Aug 06
	Lupin launches Covihalt generic Favipiravir at Rs 49 per tablet Now Lupin also launches Favipiravir for mild to moderate Covid infection... Aug 05
	Converge Biotech launches of Favipiravir in India to treat Covid-19 Converge Biotech, today announces the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ and is indicated for ... Aug 04
	Sun Pharma launches FluGuard (Favipiravir) in India at Rs. 35 per tablet Sun Pharma launches cheapest Favipiravir at Rs 35... Aug 04
	Hetero announces the launch of ‘Favivir’ in India to treat COVID-19 Hetero announces today the launch of generic Favipiravir in India under the brand name ‘Favivir... Jul 29
	Avra Laboratories get CDSCO approval for Favipiravir API Hyderabad's Avra Labs to make Favipiravir for Cipla's Ciplenza ... Jul 28
	Cipla receives DCGI approval for launch of Ciplenza Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19... Jul 27
	India COVID-19 National News Updates ; July 26 Latest on Covid developments across the states as on July 26 ... Jul 26
	After Glenmark, Jenburkt launches Favipiravir to fight COVID-19 Favivent is manufactured at a pharmaceutical plant which is compliant with US-FDA and EDQM standards... Jul 25
25 Matching result(s) found!

Trending Now
	Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
	Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
	Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
	CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
	Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
	Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
	Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
	Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026
	How Can Diabetes and High Blood Pressure Quietly Lead to Kidney Failure?September 30, 2026
	Apollo Hospitals’ “My Hands Are Ready” Sets World Record Title with 61,221 CPR Pledges in 30 DaysSeptember 30, 2026
	How Medical Device Trials and Validation Shape Safer Healthcare Innovation in IndiaSeptember 30, 2026
	Medical Device Safety in India: What Patients Should Know About Recalls and AlertsSeptember 30, 2026
	Smart Implants: How Connected Devices Could Transform Follow-Up Care in IndiaSeptember 30, 2026
	Single-Use Medical Devices: Innovation, Cost and Sustainability in Indian HealthcareSeptember 30, 2026
	11th National Convention on Medicine & Law 2026 Successfully Concludes at D Y Patil University, Navi MumbaiSeptember 29, 2026
	Can Your Skin Show the Signs of Chronic Stress? Dermatologists Explain What to Watch ForSeptember 29, 2026
	MDI Gurgaon’s Samvaad X ScaNxt NXT STEP to Put Strategic Decision-Making Under Polycrisis Conditions to TestSeptember 29, 2026
	Point-of-Care Diagnostics in India: Bringing Faster Testing Closer to PatientsSeptember 29, 2026
	Adult Vaccination in India: The Preventive Care Gap Beyond ChildhoodSeptember 29, 2026
	Maternal Nutrition Beyond Iron and Folic Acid: What Modern Prenatal Care in India Should IncludeSeptember 29, 2026